Drug Shows Promise in Slowing Multiple Sclerosis

Research appearing in the New England Journal of Medicine could herald a new treatment approach for individuals with multiple sclerosis (MS) if confirmed in future studies. The results of a clinical trial, which involved researchers from the University of Rochester Medical Center (URMC), showed that the drug ibudilast slowed the brain shrinkage associated with progressive forms of the disease.
Source: University of Rochester Medical Center Press Releases - Category: Universities & Medical Training Authors: Source Type: news